{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:46:24Z","timestamp":1782222384200,"version":"3.54.5"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>Undifferentiated endometrial carcinoma (UEC) is a rare and poorly recognized entity, associated with a poor outcome. The clinical, pathologic, and immunohistochemical features of 17 cases diagnosed at our center are described. The median age was 60\u2009yr. Postmenopausal bleeding was the most common presenting symptom (76.9%). Most patients presented with advanced stage (64.7%). Total hysterectomy with bilateral salpingo-oophorectomy was the commonly offered surgical treatment (80.0%). Nine (52.9%) patients received adjuvant treatment. The median overall survival was 11\u2009mo. Pure UEC was seen in 8 cases (47.0%), while dedifferentiated carcinoma in 5 cases (29.4%). The epithelial component was part of carcinosarcoma or was mixed with serous carcinoma in 2 cases (11.8%) each. Positivity for one or more of the cytokeratin cocktails, mostly as strong focal staining, was evident in 16 cases (94.1%). PAX-8 was negative in 13 cases (86.7%). BRG-1\/SMARCA4 was lost in 3 cases (20.0%). Eleven cases (64.7%) were MLH1\/PMS2 deficient. Ten cases (66.7%) were positive for programmed death ligand 1, with positivity in 10%, 20%, and 100% of tumor cells detected in a single case each. Only 2 of 11 (18.2%) referral cases were correctly diagnosed as UEC. UEC is a rare tumor that is frequently misdiagnosed. A panel of immunostains is necessary to make the correct diagnosis. The range of positivity for programmed death ligand 1 testing suggests that immunotherapy might be considered in the adjuvant setting, especially with the poor response of this tumor to traditional therapies.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000449","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T21:16:49Z","timestamp":1532726209000},"page":"564-574","source":"Crossref","is-referenced-by-count":31,"title":["Undifferentiated Endometrial Carcinoma, an Immunohistochemical Study Including PD-L1 Testing of a Series of Cases From a Single Cancer Center"],"prefix":"10.1097","volume":"37","author":[{"given":"Maysa","family":"Al-Hussaini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isam","family":"Lataifeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Jaradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Otay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Abu Sheikha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed","family":"Dayyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"El Khaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa","family":"Ashi Al-Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-9378(90)90399-R","article-title":"Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma","volume":"162","author":"Wilson","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/gyno.1995.1210","article-title":"Endometrial carcinoma in elderly women","volume":"58","author":"Hoffman","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.pas.0000171003.72352.9a","article-title":"Undifferentiated carcinoma of the endometrium","volume":"29","author":"Altrabulsi","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R4-20230824","first-page":"292","article-title":"Dedifferentiating endometrial adenocarcinoma. Report of a case","volume":"10","author":"Tenti","year":"1989","journal-title":"Eur J Gynaecol Oncol"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","article-title":"Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?","volume":"25","author":"Silva","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PGP.0000000000000248","article-title":"Undifferentiated carcinoma of the endometrium","volume":"35","author":"Ramalingam","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/00313020601159494","article-title":"Undifferentiated carcinoma of the endometrium: a review","volume":"39","author":"Silva","year":"2007","journal-title":"Pathology"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00125480-200405000-00001","article-title":"Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects","volume":"11","author":"Clement","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/01443615.2014.958441","article-title":"Undifferentiated uterine carcinoma: analysis of eighteen cases","volume":"35","author":"\u00dcreyen","year":"2014","journal-title":"J Obs Gynaecol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/1097-0142(19910701)68:1<98::AID-CNCR2820680120>3.0.CO;2-R","article-title":"Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases","volume":"68","author":"Abeler","year":"1991","journal-title":"Cancer"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"438","DOI":"10.5858\/arpa.2011-0461-RS","article-title":"Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked","volume":"137","author":"Al-Loh","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12253-011-9386-7","article-title":"Two cases of low-grade endometriod carcinoma associated with undifferentiated carcinoma of the uterus (dedifferentiated carcinoma): a molecular study","volume":"18","author":"Giordano","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/modpathol.2013.93","article-title":"ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma","volume":"26","author":"Romero-P\u00e9rez","year":"2013","journal-title":"Mod Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PGP.0b013e318223118a","article-title":"P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin","volume":"31","author":"Saad","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/PAS.0000000000000427","article-title":"Cyclin D1 does not distinguish YWHAE-NUTM2 high-grade endometrial stromal sarcoma from undifferentiated endometrial carcinoma","volume":"39","author":"Shah","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.humpath.2015.06.011","article-title":"Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"46","author":"Stewart","year":"2015","journal-title":"Human Pathol"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PGP.0b013e3181895539","article-title":"The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium","volume":"28","author":"Taraif","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/PAT.0000000000000270","article-title":"SWI\/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma","volume":"47","author":"Stewart","year":"2015","journal-title":"Pathology"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.anndiagpath.2015.04.001","article-title":"Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant","volume":"19","author":"Strehl","year":"2015","journal-title":"Ann Diag Pathol"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/modpathol.2015.155","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas","volume":"29","author":"Karnezis","year":"2016","journal-title":"Mod Pathol"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/his.13091","article-title":"Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology","volume":"70","author":"Ramalingam","year":"2016","journal-title":"Histopathology"},{"key":"R23-20230824","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"R24-20230824","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"AM J Surg Pathol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/PAS.0b013e3181bc9866","article-title":"Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"33019","DOI":"10.18632\/oncotarget.5028","article-title":"PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival","volume":"6","author":"Fang","year":"2015","journal-title":"Oncotarget"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.2016.213","article-title":"Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy","volume":"30","author":"Gniadek","year":"2017","journal-title":"Mod Pathol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"e1094598","DOI":"10.1080\/2162402X.2015.1094598","article-title":"Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: implication for optional anti-PD-1\/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients","volume":"5","author":"Hong","year":"2016","journal-title":"Oncoimmunology"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"e000083","DOI":"10.1136\/esmoopen-2016-000083","article-title":"Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors","volume":"1","author":"Igarashi","year":"2016","journal-title":"ESMO Open"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/2326-6066.CIR-15-0043","article-title":"Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma","volume":"3","author":"Callea","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/2326-6066.CIR-15-0197","article-title":"Radiologic heterogeneity in responses to anti-PD-1\/PD-L1 therapy in metastatic renal cell carcinoma","volume":"4","author":"de Velasco","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1158\/1078-0432.CCR-15-0244","article-title":"Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade","volume":"21","author":"Taube","year":"2015","journal-title":"Clin Can Res"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"e65821","DOI":"10.1371\/journal.pone.0065821","article-title":"PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer","volume":"8","author":"Song","year":"2013","journal-title":"PLoS One"},{"key":"R34-20230824","first-page":"11084","article-title":"Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3892\/ol.2016.4744","article-title":"Expression of PD-1, PD-L1, and PD-L2 is associated with differentiation status and histological type of endometrial cancer","volume":"12","author":"Mo","year":"2016","journal-title":"Oncol Let"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ygyno.2017.03.006","article-title":"Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors","volume":"145","author":"Bregar","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PAS.0000000000000783","article-title":"PD-L1 expression in mismatch repair-deficient endometrial carcinomas, including Lynch syndrome-associated and MLH1 promoter hypermethylated tumors","volume":"41","author":"Sloan","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00313025.2010.493871","article-title":"Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma","volume":"42","author":"Hall","year":"2010","journal-title":"Pathology"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/his.12996","article-title":"PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementation","volume":"69","author":"Cree","year":"2016","journal-title":"Histopathology"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/PAP.0b013e318234ab18","article-title":"Endometrial carcinomas","volume":"18","author":"Bartosch","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"R41-20230824","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/1066896911405987","article-title":"Dedifferentiated endometrioid adenocarcinoma of the uterus: a clinicopathologic study of a case","volume":"19","author":"Vita","year":"2011","journal-title":"Int J Surg Pathol"},{"key":"R42-20230824","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"R43-20230824","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.humpath.2011.02.004","article-title":"PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck","volume":"42","author":"Bishop","year":"2011","journal-title":"Hum Pathol"},{"key":"R44-20230824","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000214","article-title":"Endometrial stromal sarcoma involving the urinary bladder","volume":"38","author":"Tian","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R45-20230824","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000478-200204000-00001","article-title":"An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R46-20230824","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4103\/0377-4929.142689","article-title":"Cyclin D1 and p16INK4 positive endometrial stromal sarcoma: a case report with new insights","volume":"57","author":"Rekhi","year":"2014","journal-title":"Ind J Pathol Microbiol"},{"key":"R47-20230824","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.4362","article-title":"No small surprise\u2014small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour","volume":"233","author":"Foulkes","year":"2014","journal-title":"J Pathology"},{"key":"R48-20230824","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2017","journal-title":"Cancer Res"},{"key":"R49-20230824","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"R50-20230824","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0000000000000554","article-title":"SWI\/SNF complex-deficient undifferentiated\/rhabdoid carcinomas of the gastrointestinal tract","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R51-20230824","doi-asserted-by":"crossref","DOI":"10.1007\/s12105-017-0783-4","article-title":"SMARCA4-deficient sinonasal carcinoma","author":"Agaimy","year":"2017","journal-title":"Head Neck Pathol"},{"key":"R52-20230824","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J Immunol"},{"key":"R53-20230824","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/PPO.0000000000000179","article-title":"Immune checkpoint inhibitors in the treatment of gynecologic malignancies","volume":"22","author":"Ring","year":"2016","journal-title":"Cancer J"},{"key":"R54-20230824","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.18632\/oncotarget.6429","article-title":"Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma","volume":"7","author":"Darb-Esfahani","year":"2016","journal-title":"Oncotarget"},{"key":"R55-20230824","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2016.03.008","article-title":"PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer","volume":"141","author":"Webb","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R56-20230824","doi-asserted-by":"crossref","first-page":"42929","DOI":"10.1038\/srep42929","article-title":"Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer","volume":"7","author":"Aust","year":"2017","journal-title":"Scien Rep"},{"key":"R57-20230824","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ygyno.2016.12.021","article-title":"Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: a comparison of matched primary and metastatic tumors","volume":"144","author":"Gottlieb","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R58-20230824","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.18632\/oncotarget.7277","article-title":"Association and prognostic significance of BRCA1\/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1\/PD-L1 in high grade serous ovarian cancer","volume":"7","author":"Strickland","year":"2016","journal-title":"Oncotarget"},{"key":"R59-20230824","doi-asserted-by":"crossref","first-page":"e1277308","DOI":"10.1080\/2162402X.2016.1277308","article-title":"Clear cell ovarian cancers with microsatellite instability: a unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1\/PD-L1 expression","volume":"6","author":"Howitt","year":"2017","journal-title":"Oncoimmunology"},{"key":"R60-20230824","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13048-017-0304-9","article-title":"Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy","volume":"10","author":"Li","year":"2017","journal-title":"J Ovar Res"},{"key":"R61-20230824","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol"},{"key":"R62-20230824","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2016.06.008","article-title":"Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy?","volume":"48","author":"Gargiulo","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"R63-20230824","doi-asserted-by":"crossref","first-page":"e1264565","DOI":"10.1080\/2162402X.2016.1264565","article-title":"Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition","volume":"6","author":"Eggink","year":"2016","journal-title":"Oncoimmunology"},{"key":"R64-20230824","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00262-014-1537-8","article-title":"Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy","volume":"63","author":"Vanderstraeten","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"R65-20230824","article-title":"PD-L1 expression in carcinosarcomas of the gynecologic tract","author":"Pinto","year":"2016","journal-title":"App Immunohist Mol Morphol"},{"key":"R66-20230824","doi-asserted-by":"crossref","first-page":"e0170879","DOI":"10.1371\/journal.pone.0170879","article-title":"Clinical significance of programmed death ligand-1 and intra-tumoral CD8+ T lymphocytes in ovarian carcinosarcoma","volume":"12","author":"Zhu","year":"2017","journal-title":"PLOS One"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201811000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:33:52Z","timestamp":1692840832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201811000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000449","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}